Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:8
|
作者
Fritz, Megan Kunka [1 ]
Kincaid, Scott E. [1 ]
Sargent, Charles G. [2 ]
Green, Amanda H. [3 ]
Davis, George A. [1 ]
机构
[1] Univ Kentucky HealthCare, Pharm Dept, 800 Rose St, Lexington, KY 40536 USA
[2] Univ Kentucky HealthCare, Div Hosp Med, 800 Rose St, Lexington, KY 40536 USA
[3] Univ Kentucky HealthCare, Dept Nursing, 800 Rose St, Lexington, KY 40536 USA
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin; PROPHYLAXIS; PREVENTION; GUIDELINES; THROMBOSIS; MODEL;
D O I
10.1007/s11239-020-02144-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers' VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined. Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection. Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study. A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
下载
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
  • [21] Pharmacological prevention of venous thromboembolism in medical patients at risk
    Wolozinsky M.
    Yavin Y.Y.
    Cohen A.T.
    American Journal of Cardiovascular Drugs, 2005, 5 (6) : 409 - 415
  • [22] The "Risk" of Risk Assessment Models for Venous Thromboembolism in Medical Patients
    Spyropoulos, Alex C.
    Anderson, Frederick A.
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (11): : E23 - E24
  • [23] Venous thromboembolism risk assessment in medical patients.
    Cohen, AT
    Alikhan, R
    Arcelus, J
    Haas, S
    Spyropoulos, A
    Tapson, V
    Turpie, AGG
    BLOOD, 2002, 100 (11) : 280A - 280A
  • [24] Changing Practice: Implementation of a Venous Thromboembolism Prophylaxis Protocol at an Academic Medical Center
    Pannucci, Christopher J.
    Jaber, Reda M.
    Zumsteg, Justin M.
    Golgotiu, Vlad
    Spratke, Lisa M.
    Wilkins, Edwin G.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 128 (05) : 1085 - 1092
  • [25] Risk Stratification for Prevention of Venous Thromboembolism in Hospitalized Medical Patients: Can thromboprophylaxis in hospitalized medical patients be safely restricted to reduce costs?
    Bond, Alison
    Walker, Scott
    Diamantouros, Artemis
    Geerts, William
    THROMBOSIS RESEARCH, 2018, 170 : 3 - 3
  • [26] Guidelines for venous thromboembolism (VTE) prevention in hospitalised medical patients: a validation study pilot
    Chapman, N. H.
    Lassere, M. N.
    Clarke, M.
    Chong, B. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 654 - 654
  • [27] Monitoring of prescriptions on prophylaxis of venous thromboembolism (VTE) in medical patients in Beatriz Angelo Hospital
    Tata, F.
    Soares, L.
    Cardoso, P.
    Figueiredo, R.
    Lobo, T.
    Capoulas, M.
    Loba, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 248 - 248
  • [28] Impact of Venous Thromboembolism (VTE) Prophylaxis and Risk Stratification with the Caprini Model in Hospitalized Patients with Cancer
    Ruch, Joshua M.
    Hu, Hsou M.
    Bahl, Vinita
    Sood, Suman L.
    BLOOD, 2012, 120 (21)
  • [29] Are we assessing venous thromboembolism (VTE) risk appropriately for hospitalised medical patients? The National VTE Risk Assessment Tool versus Padua Prediction Score
    Chandra, Deepak
    Dabhi, Keval
    Lester, Will
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : E16 - E18
  • [30] Utilization of IMPROVEDD VTE Risk Score for Venous Thromboembolism (VTE) Risk Stratification in COVID-19 Pneumonia
    Tahanulquiwa, H.
    Goel, M.
    Zaidi, W.
    Aggarwal, A.
    Kumar, S.
    Tegeltija, V.
    Rao, N.
    Ahmed, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205